Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

IL-6 promotes NK cell production of IL-17 during toxoplasmosis.

Passos ST, Silver JS, O'Hara AC, Sehy D, Stumhofer JS, Hunter CA.

J Immunol. 2010 Feb 15;184(4):1776-83. doi: 10.4049/jimmunol.0901843. Epub 2010 Jan 18.

2.

The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii.

Hunter CA, Ellis-Neyer L, Gabriel KE, Kennedy MK, Grabstein KH, Linsley PS, Remington JS.

J Immunol. 1997 Mar 1;158(5):2285-93.

PMID:
9036976
3.

Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii.

Cai G, Radzanowski T, Villegas EN, Kastelein R, Hunter CA.

J Immunol. 2000 Sep 1;165(5):2619-27.

4.
5.

Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii.

Caamaño J, Tato C, Cai G, Villegas EN, Speirs K, Craig L, Alexander J, Hunter CA.

J Immunol. 2000 Nov 15;165(10):5720-8.

6.

Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii.

Neyer LE, Grunig G, Fort M, Remington JS, Rennick D, Hunter CA.

Infect Immun. 1997 May;65(5):1675-82.

9.

Natural killer cell intrinsic toll-like receptor MyD88 signaling contributes to IL-12-dependent IFN-γ production by mice during infection with Toxoplasma gondii.

Ge Y, Chen J, Qiu X, Zhang J, Cui L, Qi Y, Liu X, Qiu J, Shi Z, Lun Z, Shen J, Wang Y.

Int J Parasitol. 2014 Jun;44(7):475-84. doi: 10.1016/j.ijpara.2014.03.004. Epub 2014 Apr 13.

PMID:
24727091
11.

In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.

Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, Hieny S, Gazzinelli RT, Sher A.

J Immunol. 1996 Nov 1;157(9):4045-54.

PMID:
8892638
12.

The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii.

Caamaño J, Alexander J, Craig L, Bravo R, Hunter CA.

J Immunol. 1999 Oct 15;163(8):4453-61.

13.

Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii.

Cai G, Kastelein R, Hunter CA.

Infect Immun. 2000 Dec;68(12):6932-8.

14.
15.

Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii.

Koblansky AA, Jankovic D, Oh H, Hieny S, Sungnak W, Mathur R, Hayden MS, Akira S, Sher A, Ghosh S.

Immunity. 2013 Jan 24;38(1):119-30. doi: 10.1016/j.immuni.2012.09.016. Epub 2012 Dec 13.

16.

Flt3 Ligand Is Essential for Survival and Protective Immune Responses during Toxoplasmosis.

Dupont CD, Harms Pritchard G, Hidano S, Christian DA, Wagage S, Muallem G, Tait Wojno ED, Hunter CA.

J Immunol. 2015 Nov 1;195(9):4369-77. doi: 10.4049/jimmunol.1500690. Epub 2015 Sep 18.

17.

The aryl hydrocarbon receptor promotes IL-10 production by NK cells.

Wagage S, John B, Krock BL, Hall AO, Randall LM, Karp CL, Simon MC, Hunter CA.

J Immunol. 2014 Feb 15;192(4):1661-70. doi: 10.4049/jimmunol.1300497. Epub 2014 Jan 8.

18.

Host resistance and immune deviation in pigeon cytochrome c T-cell receptor transgenic mice infected with Toxoplasma gondii.

Collazo CM, Miller C, Yap G, Hieny S, Caspar P, Schwartz RH, Sher A.

Infect Immun. 2000 May;68(5):2713-9.

19.

Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice.

Liu CH, Fan YT, Dias A, Esper L, Corn RA, Bafica A, Machado FS, Aliberti J.

J Immunol. 2006 Jul 1;177(1):31-5.

20.

The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology.

Hall AO, Beiting DP, Tato C, John B, Oldenhove G, Lombana CG, Pritchard GH, Silver JS, Bouladoux N, Stumhofer JS, Harris TH, Grainger J, Wojno ED, Wagage S, Roos DS, Scott P, Turka LA, Cherry S, Reiner SL, Cua D, Belkaid Y, Elloso MM, Hunter CA.

Immunity. 2012 Sep 21;37(3):511-23. doi: 10.1016/j.immuni.2012.06.014. Epub 2012 Sep 13.

Supplemental Content

Support Center